Cost-Effectiveness of Disease- Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective
Advertisement
Advertisement
Trending on AJMC
1
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
2
ACA Enrollment Erosion Deepens After Open Enrollment Ends
3
Efgartigimod Effective in Broad Subsets of Patients With gMG
4
Alopecia Areata Takes a Hidden Toll on Work, Relationships, and Self-Care
5